Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06847906 · ClinicalTrials.gov registry record · NA

Evaluating the Reach of Clinical Decision Support for Patients With Heart Failure

A NA study of Heart Failure and Decision Support Systems, Clinical, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06847906: Recruiting NA study of Heart Failure and Decision Support Systems, Clinical, sponsored by University of Colorado, Denver.

NCT06847906 is a NA study of Heart Failure and Decision Support Systems, Clinical that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 500 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06847906, a NA study of Heart Failure and Decision Support Systems, Clinical, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

To work best, clinical decision support tools (CDS) must be timed to provide support when healthcare decisions are made, which includes virtual visits (phone or video). Unfortunately, most CDS tools are either missing from virtual visits or not designed for the unique context of virtual visits (e.g., availability of physical assessments and labs, different workflows), which could generate new inequities for patients more likely to use virtual visits. The objective of this study is to test the reach, feasibility and acceptability of a new CDS tool for heart failure with reduced ejection fraction (HFrEF) during virtual visits. This new CDS tool was developed through an iterative design process, and will be compared to an existing HFrEF CDS tool in a randomized pilot study at outpatient cardiology clinics throughout the UCHealth system.

Primary Outcome

The primary outcome is number of CDS alerts that resulted in the prescription of the medication recommended by the CDS alert. Recommended medications include either evidence-based beta blockers, sacubitril/valsartan, mineralocorticoid receptor antagonists or sodium/glucose cotransport 2 inhibitors. Prescriptions will be based on actual prescription orders instead of clinician-stated responses, given the latter may overestimate effectiveness.

Interventions

  • OTHER Iteratively designed (new) clinical decision support tool for virtual visits
  • OTHER Traditional clinical decision support tool

Study Locations (1)

Colorado

  • UCHealth Primary Care and Cardiology Outpatient Clinics - Aurora

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-02-25
Est. Completion 2026-01-01
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT06847906 shows while recruiting

NCT06847906 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower).

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Iteratively designed (new) clinical decision support tool for virtual visits is the first listed.

NCT06847906 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT06847906 about?

NCT06847906 is a clinical study titled "Evaluating the Reach of Clinical Decision Support for Patients With Heart Failure". To work best, clinical decision support tools (CDS) must be timed to provide support when healthcare decisions are made, which includes virtual visits (phone or video). Unfortunately, most CDS tools are either missing from virtual visits or not designed for the unique context of virtual visits (e.g....

What is the current status of trial NCT06847906?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-02-25. Estimated completion is 2026-01-01.

What conditions does trial NCT06847906 study?

This clinical trial studies the following conditions: Heart Failure, Decision Support Systems, Clinical.

What interventions are being tested in trial NCT06847906?

The interventions under investigation include: Iteratively designed (new) clinical decision support tool for virtual visits (OTHER), Traditional clinical decision support tool (OTHER).

Who is sponsoring clinical trial NCT06847906?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06847906 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06847906's enrollment target sits among peer trials

500 101st of 397 higher than 294 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06847906, the US trial registry maintained by the National Library of Medicine. NCT06847906 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.